Participation of African Americans in a smoking cessation trial: A quantitative and qualitative study

Journal of the National Medical Association

Volumn 94, Issue 7, 2002, Pages 609-618

  Woods, Malaika N ^a   Harris, Kari Jo ^a,b   Mayo, Matthew S ^a,b   Catley, Delwyn ^a,b   Scheibmeir, Monica ^c   Ahluwalia, Jasjit S ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF NURSING   (United States)

Author keywords

African Americans; Clinical trials; Participation; Randomization

Indexed keywords

AMFEBUTAMONE; DOPAMINE UPTAKE INHIBITOR;

ADULT; AFRICAN AMERICAN; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ETHNOLOGY; FEMALE; HUMAN; INFORMATION PROCESSING; MALE; METHODOLOGY; MOTIVATION; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION;

ADULT; AFRICAN AMERICANS; BUPROPION; DOPAMINE UPTAKE INHIBITORS; FEMALE; FOCUS GROUPS; HUMANS; MALE; MOTIVATION; PATIENT ACCEPTANCE OF HEALTH CARE; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SMOKING CESSATION;

EID: 0036631968     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Roberson NL. Clinical trial participation: viewpoints from racial ethnic groups. CANCER Supplement 1994;74:2687-2691.
2. Holcombe R, Jacobson J, Li A, Moinpour C. Inclusion of black Americans in oncology clinical trials: the Louisiana state university medical center experience. Am J Clin Oncol 1998;22: 18-21.
3. Swanson G, Ward A. Recruiting minorities into clinical trials: toward a participant-friendly system. J Natl Cancer Inst 1995;87:1747-1759.
4. El-Sadr W, Capps L. The challenge of minority recruitment in clinical trials for AIDS. JAMA 1992;267:954-957.
5. Millon-Underwood S, Sanders E, Davis M. Determinants of participation in state-of-the-art cancer prevention, early detection screening, and treatment trials among African-Americans. Cancer Nursing 1993;16:25-33.
6. Kaluzny A, Brawley O, Garson-Angert D, et al. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the minority based community clinical oncology program. J Natl Cancer Inst 1993;85:1945-1950.
7. USDHHS. Healthy people 2000: National health promotion and disease prevention objectives full report with commentary. Washington, D.C.: Government Printing Office, 1991.
8. Diaz T, Chu S, Sorvillo F. Differences in participation in experimental drug trials among persons with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:562-568.
9. Richardson M, Post-White J, Singletary S, Justice B. Recruitment for complementary alternative medicine trials: Who participates after breast cancer. Ann Behav Med 1998;20:190-198.
10. Moorman PG, Newman B, Millikan RC, Tse CK, Sandler DP. Participation rates in a case-control study: the impact of age, race, and race of interviewer. Aim Epidemiol 1999;9:188-95.
11. Kviz F, Crittenden K, Warnecke R. Factors associated with nonparticipation among registrants for a self-help community-based smoking cessation intervention. Addict Behav 1992;17: 533-542.
12. Schwartz CE, Fox BH. Who says yes? Identifying selection biases in a psychosocial intervention study of multiple sclerosis. Soc Sci Med 1995;40:359-370.
13. Brown DR FM, Basen-Engquist K, Tortolero-Luna G. Recruitment and retention of minority women in cancer screening, prevention, and treatment trials. Ann Epidemiol 2000;10: S13-21.
14. Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med 1999;14: 537-546.
15. Mouton CP, Harris S, Rovi S, Solorzano P, Johnson MS. Barriers to black women's participation in cancer clinical trials. J Natl Med Assoc. 1997;89:721-727.
16. Harris Y, Gorelick PB, Samuels P, Bempong I. Why African Americans may not be participating in clinical trials. J Natl Med Assoc. 1996;88:630-634.
17. Koblin BA, Avrett S, Taylor PE, Stevens CE. Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in New York City: Project ACHIEVE. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:165-71.
18. Gorelick PB, Harris Y, Burnett B, Bonecutter F. The recruitment triangle: Reasons why African Americans enroll, refuse to enroll, or voluntarily withdraw from a clinical trial. J Natl Med Assoc. 1998;90:141-145.
19. Tangrea JA. Patient participation and compliance in cancer chemoprevention trials: issues and concerns. Proc Soc Exp Biol Med 1997;216:260-5.
20. MacQueen KM, Vanichseni S, Kitayaporn D. Willingness of injection drug users to praticipate in an HIV vaccine efficacy trial in Bangkok Thailand. JAIDS 1999;21:243-251.
21. Morse EV, Simon PM, Besch CL, Walker J. Issues of recruitment retention and compliance in community based clinical trials with traditionally underserved populations. Appl Nurs Res 1995;8:8-14.
22. Mansour EG. Barriers to clinical trials. Part III: Knowledge and attitudes of health care providers. Cancer 1994;74: 2672-5.
23. Crosson R, Eisner E, Brown C, Ter Maat J. Primary care physicians' attitudes, knowledge, and practices related to cancer clinical trials. J Cancer Educ 2001;16:188-92.
24. Simon MS, Brown DR, Du W, LoRusso P, Kellogg CM. Accrual to breast cancer clinical trials at a university affiliated hospital in metropolitan Detroit. Am J Clin Oncol 1999;22:42-46.
25. Lara N, Higdon R, Lim N, et. al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol 2001;19:1728-1733.
26. Pohl JM, Martinelli A, Antonakos C. Predictors of participation in a smoking cessation intervention group among low income women. Addict Behav 1998;23:699-704.
27. Ahluwalia JS, Harris KJ, Catley D, Okuyemi KS, Mayo MS. A comparison of sustained-release bupropion and placebo for smoking cessation in African Americans. Nicotine and Tobacco Research (in press);Abstract.
28. Harris KJ, Ahluwalia JS, Catley D, et al. Successful recruitment of minorities into clinical trials: the kick it at swope project. Nicotine and Tobacco Research (in press).
29. Ahluwalia JS. Smoking cessation in African Americans. Am J Health Behav 1996;20:312-318.
30. Weissman MM, Sholomakis D, Pottenger M, Prusoff B, Locke BZ. Assessing depressive symptoms in five psychiatric populations: A validation study. Am J Epidemiol 1977;106:203-214.
31. Romano PS, Bloom J, Syme SL. Smoking social support and hassles in an urban African American community. Am J Public Health 1991;81:1415-1422.
32. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K. The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom tolerance questionnaire. Br J Addict 1991;86: 1119-1127.
33. QSR.N4 (Non-numerical unstructured data indexing searching and theorizing) qualitative data analysis program. Melbourne, AU: Qualitative Solution Research Pty Ltd, 1998.
34. Krueger RA. Focus groups: A practical guide for applied research. Thousand Oaks, CA: SAGE Publications, Inc, 1994.
35. Damron D, Langenberg P, Anliker J, Ballesteros M, Feldman R, Havas S. Factors associated with attendance in a voluntary nutrition education program. Am J Health Promot 1999;13:268-275.
36. Woods MN, Harris KJ, Ahlwualia JS, Schmelzle K, Mayo MS. Smoking in urban African Americans: behaviors, gender differences, and motivation to quit. Ethn Dis 2001;11:532-539.
37. Paskett ED, DeGraffinreid C, Tatum CM, Margitic SE. The recruitment of African-Americans to cancer prevention and control studies. Prev Med 1996;25:547-553.